Notwithstanding something unforeseen happening, I agree... it seems plain to me that 4DX is cornering the diagnostic market for lungs (functional and structural)... with time, as the utility, precision and (hopefully) improved outcomes for patients become clear through the VA, it may likely become part of the standard offering throughout the American health system.
4DX Chart, page-692
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
0.015(2.86%) |
Mkt cap ! $221.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.0¢ | 51.5¢ | $226.9K | 431.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16886 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 41547 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |